Statistics
Publications
8
Citations
386
H-Index
8
Active since
2019
Amy E. Schade is an author at Harvard University specializing in molecular oncology, oncology, and life sciences.
Publications per year
2019–2024
8
8
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
Amy E. Schade, Naiara Perurena, Yoona Yang et al. · Nature · 2024 · 55 citations · Full text
Medicine, Oncology, Pharmacology +17
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity
Timothy B. Branigan, David Kozono, Amy E. Schade et al. · Cell Reports · 2021 · 52 citations · Full text
1–5 of 8